10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of September 13, 2026, TXG trades at $68.88 with a market cap of $8.94B and a P/E ratio of -116.74. TXG moved +3.42% today. Year to date, TXG is +320.54%; over the trailing twelve months it is +425.19%. Its 52-week range spans $6.78 to $69.67. Analyst consensus is buy with an average price target of $52.00. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TXG insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $68.88 |
| Market Cap | $8.94B |
| P/E Ratio | -116.74 |
| EPS | $-0.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $69.67 |
| 52-Week Low | $6.78 |
| Volume | 1.56M |
| Avg Volume | 0 |
| Revenue (TTM) | $616.91M |
| Net Income | $-75.13M |
| Gross Margin | 70.03% |
14 analysts cover TXG: 0 strong buy, 6 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $52.00.